The controlled release drug delivery market involves formulation technologies and systems for controlled or sustained release of therapeutic agents inside the body over specific periods. Controlled release drug delivery systems are designed to improve drug therapy by releasing medicinal substances in a pre-programmed and predetermined rate, time, dosage, or location-specific manner. This helps in maintaining steady-state plasma concentrations of drugs, reducing dosing frequency, increasing patient compliance, and minimizing toxic side effects. The major advantages include locally high drug concentration at disease site, lowering drug dose required, reducing side effects and improving efficacy of treatments.
Key Takeaways
Key players operating in the controlled release drug delivery market are Orbis Biosciences, Inc., Merck and Co., Inc., Alkermes plc, Johnson and Johnson, Coating Place, Inc., Corium International, Inc., Depomed, Inc., Pfizer, Inc, Aradigm Corporation, Capsugel., Abbott Laboratories, Roche Holdings AG, AstraZeneca, Baxter International Inc, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company. These players are focusing on developing advanced drug delivery formulations and systems for targeted therapeutic applications.
The growing prevalence of chronic diseases along with rise in geriatric population globally is expected to drive Controlled Release Drug Delivery Market Demand. Controlled release formulations help in improving patient compliance for chronic disease management by reducing dosing frequency.
The controlled release drug delivery market is expanding rapidly across global regions led by growing investments in pharmaceutical R&D and clinical trials. Furthermore, developing economies are expected to witness higher growth owing to increasing healthcare expenditure, healthcare reforms for ensuring accessibility and affordability.
Market Key Trends
Targeted drug delivery is one of the key trends gaining significant attention in the controlled release drug delivery market. Nano-mediated drug delivery and drug conjugates are being researched for development of advanced targeted therapeutic systems with ability to carry drugs to specific cells and tissues. This helps in overcoming challenges associated with conventional dosage forms such as non-specific biodistribution and low bioavailability at target sites. Rising focus on precision and personalized medicine will further propel innovations in targeted controlled release formulations.
Get more insights on Controlled Release Drug Delivery Market
For More Insights Discover the Report In language that Resonates with you:-
